Halk sağlığı bakış açısıyla teletıp

Year 2021, , 295 - 303, 02.12.2021

Deren Özyürek Ucael , Mustafa Özden , Ercüment Altıntaş Dilek Aslan

https://doi.org/10.20518/tjph.894701

Cited By: 1

Abstract

Teletıp, tıbbın “sanal” olanakların kullanılabildiği uygulama alanları arasındadır. Geçmişte de uygulanmasına rağmen, Yeni Koronavirüs Hastalığı (COVID-19) pandemisinde teknoloji kullanımındaki artma eğilimi nedeniyle günümüzde teletıp uygulamaları daha popüler olmuştur. Bu makalede, teletıbbın güçlü yanları ve sınırlılıkları halk sağlığı bakış açısıyla tartışılmıştır. İçerikte uygulamaların koruyucu hekimlik boyutuna da değinilmiştir. Günümüzde, sağlık hizmetlerinin maliyetini azaltmak, sağlığa olan erişimi artırmak, kronik hastalıklarda teletıbbın uygulanmasını geliştirmek, sağlık çalışanlarının teletıp altyapısının var olduğu her yerden sağlık hizmeti sunmasını sağlamak, sağlık çalışanlarını teletıp
uygulamalarını kullanmaya teşvik etmek ve sağlık profesyonelleri arasında multidisipliner çalışmayı desteklemek gibi gerekçelere bağlı olarak teletıp uygulamalarında artma eğilimi vardır. Güncel teletıp uygulamaları eş zamanlı, eş zamanlı olmayan ve uzaktan hasta izlemi şeklinde hem klinik uygulamalarda hem koruyucu hekimlik alanında kullanılmaya devam etmektedir. Teletıp uygulamalarıyla ilgili olarak; standardizasyon ve nitelik sorunları, hastahekim iletişiminin yetersizliği, verilerin saklanmasındaki problemler, ucuz iş gücü gibi sınırlılıklar öne çıkmaktadır. Teletıp uygulamalarının tıbbın bütün alanlarında uygulanmasını desteklemek ve uygulamaların mevcut kısıtlılıklarına çözüm üretebilmek için halk sağlığı
bakış açısının yararlı olacağı düşünülmektedir.

Keywords

teletıp, sağlık hizmeti, koruyucu hekimlik

Telemedicine in public health perspective

Abstract

Telemedicine is among medical practices where “virtual” opportunities can be used. Although it has a historical background, telemedicine has become more popular due to the increasing trend in technology use in Novel Coronavirus Disease (COVID-19) pandemic. In this article, telemedicine use has been discussed with its strengths and limitations in public health perspective. Preventive medicine dimension has also been tackled in the content. Today, there is an increasing trend in telemedicine use due to some reasons including reducing health care cost, increasing access to health care services, promoting telemedicine use in chronic diseases, enabling healthcare professionals to provide healthcare services where telemedicine infrastructure is accessible, encouraging healthcare professionals to use telemedicine, and supporting multidisciplinary work of health professionals. Current telemedicine
applications continue to be used both in clinical practice and in preventive medicine in “simultaneous”, “asynchronous” and “remote patient monitoring” formats. Limitations of telemedicine including standardization and quality problems, insufficient patient-physician communication, problems in data storage, cheap labor, have become prominent. Public health perspective is thought to be helpful to promote telemedicine use in all fields of medicine and to propose solutions for its current limitations.

Keywords

telemedicine, health service, preventive medicine

References

• WHO, Telemedicine: opportunities and developments in Member States: report on the second global survey on eHealth 2009 Available at: https://www.who.int/goe/publications/goe_telemedicine_2010.pdf[online] Accessed January 21, 2021
• CDC, Telehealth and Telemedicine Available at: www.cdc.gov/phlp/publications/topic/telehealth.html. [online] Accessed January 21, 2021
• Board on Health Care Services; Institute of Medicine. The Role of Telehealth in an Evolving Health Care Environment: Workshop Summary. Washington (DC): National Academies Press (US); 2012 Nov
• Maheu M, Whitten P, Allen A, Jossey-Bass. The Evolution of Telehealth: Where Have We Been and Where Are We Going?: E-health, telehealth, and telemedicine [online] Accessed January 21, 2021.
• Nesbitt T.S., & Katz-Bell J (). History of telehealth. Rheuban K, & Krupinski E.A.(Eds.), Understanding Telehealth. McGraw-Hill. https://accessmedicine. m h m e d i c a l . c o m / c o n t e n t . aspx bookid=2217&sectionid=187794434 [online] Accessed January 26, 2021.
• Rheuban K, & Krupinski E.A.(Eds.), (). Understanding Telehealth. McGraw-Hill. Available at:https://accessmedicine.mhmedical.com/content.aspx?bookid=2217&sectionid=187794154 [online] Accessed January 26, 2021.
• Hyder M, Razzak J Telemedicine in the United States: An Introduction for Students and Residents J Med Internet Res 2020;22(11):e20839 Available at: www.jmir.org/2020/11/e20839. Accessed January 26, 2021.
• WHO, International Safe Abortion Day, Available at: https://www.who.int/news/item/28-09-2020 internationalsafe-abortion-day. [online] Accessed January 26, 2021.
• WHO, WHO releases first guideline on digital health interventions, Available at: www.who.int/news/item/17-04-2019-who-releases-first-guideline-on-digitalhealth-interventions. [online] Accessed January 26, 2021.
• American College of Preventive Medicine (ACPM), What is Preventive Medicine?, Available at:https://www.acpm.org/about-acpm/what-is-preventivemedicine. [online] Accessed February 12, 2021.
• WHO, WHO releases first guideline on digital health interventions, Available at: www.who.int/news/item/17-04-2019-who-releases-first-guideline-on-digitalhealth-interventions. [online] Accessed January 26, 2021.
• WHO, International Safe Abortion Day, Available at: https://www.who.int/news/item/28-09-2020-internationalsafe-abortion-day. [online] Accessed January 26, 2021.
• Tozzi A. E, Gesualdo F, D’Ambrosio A, Pandolfi E, Agricola E, Lopalco P. Can digital tools be used for improving immunization programs?. Frontiers in public health. 2016 Mar 8;4:36. Accessed January 26, 2021.
• T.C. Sağlık Bakanlığı, Sigara Bırakma Hizmetleri, Available at:https://hsgm.saglik.gov.tr/tr/bagimliliklamucadelehaberler/sigara-birakma-hizmetleri.html. Accessed February 02, 2021.
• Dr. e-nabız, Avaliable at: https://dr.enabiz.gov.tr/#/. [online] Accessed February 20, 2021.
• T.C. Sağlık Bakanlığı, Hayat Eve Sığar Programı, Avaliable at: https://covid19.saglik.gov.tr/TR-66234/hayat-evesigar-mobil-uygulamasi.html. [online] Accessed January 27, 2021.
• Chatwin J, Butler D, Jones J, et al. Experiences of pregnant mothers using a social media based antenatal support service during the COVID-19.lockdown in the UK: findings from a user survey. BMJ Open 2021;11:e040649.
• T.C. Sağlık Bakanlığı, Sigara Bırakma Hizmetleri, Available at:https://hsgm.saglik.gov.tr/tr/bagimliliklamucadelehaberler/sigara-birakma-hizmetleri.html. [online] Accessed February 08, 2021.
• Dorsey ER, Topol EJ. State of Telehealth. N Engl J Med. 2016 Jul 14;375(2):154-61. PMID: 27410924.
• Aghdam MRF, Vodovnik A, Hameed RA. Role of Telemedicine in Multidisciplinary Team Meetings. J Pathol Inform. 2019 Nov 18;10:35. PMID: 31799021; PMCID:PMC6883478. Public health and telemedicine
• Shigekawa E, Fix M, Corbett G, Roby DH, Coffman J. The Current State Of Telehealth Evidence: A Rapid Review. Health Aff (Millwood). 2018 Dec;37(12):1975-1982. PMID: 30633674.
• Chaet D, Clearfield R, Sabin JE, Skimming K; Council on Ethical and Judicial Affairs American Medical Association. Ethical practice in Telehealth and Telemedicine. J Gen Intern Med. 2017 Oct;32(10):1136-1140. Epub 2017 Jun 26. PMID:28653233; PMCID: PMC5602756.).
• Clark PA, Capuzzi K, Harrison J. Telemedicine: medical, legal and ethical perspectives. Med Sci Monit. 2010 Dec;16(12):RA261-72. PMID: 21119593.
• Bashshur RL, Howell JD, Krupinski EA, Harms KM, Bashshur N, Doarn CR. The Empirical Foundations of Telemedicine Interventions in Primary Care. Telemed JE Health. 2016 May;22(5):342-75. PMID: 27128779; PMCID: PMC4860623.
• Lee JY, Lee SWH. Telemedicine CostEffectiveness for Diabetes Management: A Systematic Review. Diabetes Technol Ther. 2018 Jul;20(7):492-500. Epub 2018 May 29. PMID: 29812965.
• Jiang X, Ming WK, You JH. The CostEffectiveness of Digital Health Interventions on the Management of Cardiovascular Diseases: Systematic Review. J Med Internet Res. 2019 Jun 17;21(6):e13166. PMID:31210136; PMCID: PMC6601257.